Cargando…
Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?
Introduction Dose adjustment based on laboratory monitoring is not routinely recommended for patients treated with rivaroxaban but because an association has been reported between high drug level and bleeding, it would be of interest to know if measuring drug level once could identify patients at r...
Autores principales: | Shyamkumar, Krishnan, Hirsh, Jack, Bhagirath, Vinai C., Ginsberg, Jeffrey S., Eikelboom, John W., Chan, Noel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906835/ https://www.ncbi.nlm.nih.gov/pubmed/33655194 http://dx.doi.org/10.1055/s-0040-1721734 |
Ejemplares similares
-
Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study
por: de Vries, Tim A.C., et al.
Publicado: (2022) -
Carbamazepine, phenytoin, and oral anticoagulants: Drug‐drug interaction and clinical events in a retrospective cohort
por: Candeloro, Matteo, et al.
Publicado: (2022) -
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES Trial
por: Bhagirath, Vinai C., et al.
Publicado: (2017) -
Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism
por: Chan, Noel C, et al.
Publicado: (2015) -
Prevention of Venous Thromboembolism in 2020 and Beyond
por: Nicholson, Matthew, et al.
Publicado: (2020)